These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31233404)

  • 1. Observational Study Examining the Diagnostic Practice of Ki67 Staining for Melanocytic Lesions.
    Vyas NS; Charifa A; Desman GT; Goldberg M; Singh R; Phelps RG; McNiff JM
    Am J Dermatopathol; 2019 Jul; 41(7):488-491. PubMed ID: 31233404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
    Garola R; Singh V
    Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions.
    Nielsen PS; Riber-Hansen R; Steiniche T
    Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
    Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
    Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Another point of view on p16 and Ki67 expression in melanocytic and non-melanocytic cutaneous lesions.
    Donati P; Paolino G; Panetta C; Cota C; Zaccarini M; Muscardin L
    Acta Dermatovenerol Croat; 2013; 21(3):149-54. PubMed ID: 24183217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases.
    Harvell JD; Bastian BC; LeBoit PE
    Am J Surg Pathol; 2002 May; 26(5):654-61. PubMed ID: 11979096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
    Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
    Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.
    Kapur P; Selim MA; Roy LC; Yegappan M; Weinberg AG; Hoang MP
    Mod Pathol; 2005 Feb; 18(2):197-204. PubMed ID: 15467715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nestin Expression in Spitzoid Lesions: An Immunohistochemical Characterization With Clinical and Dermoscopic Correlations.
    Guanziroli E; Del Gobbo A; Coggi A; Venegoni L; Fanoni D; Ercoli G; Boggio F; Veraldi S; Cavicchini S; Berti E; Ferrero S; Gianotti R
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):430-435. PubMed ID: 30212379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
    Soon AK; Brownstein S; Tang T; Saleh S; Jiang K; Levac J; Blanco P; Farmer J
    Can J Ophthalmol; 2019 Dec; 54(6):699-707. PubMed ID: 31836103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical melanocytic lesions: a historical overview.
    Manchi M; Canzonieri V
    Pol J Pathol; 2019; 70(1):26-32. PubMed ID: 31556548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate identification of proliferative index in melanocytic neoplasms with Melan-A/Ki-67 double stain.
    Puri PK; Valdes CL; Burchette JL; Grichnik JM; Turner JW; Selim MA
    J Cutan Pathol; 2010 Sep; 37(9):1010-2. PubMed ID: 20002650
    [No Abstract]   [Full Text] [Related]  

  • 14. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
    Isabel Zhu Y; Fitzpatrick JE
    J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated quantification of Ki67/MART1 stains may prevent false-negative melanoma diagnoses.
    Wandler A; Spaun E; Steiniche T; Nielsen PS
    J Cutan Pathol; 2016 Nov; 43(11):956-962. PubMed ID: 27461337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.
    Barnhill RL; Argenyi ZB; From L; Glass LF; Maize JC; Mihm MC; Rabkin MS; Ronan SG; White WL; Piepkorn M
    Hum Pathol; 1999 May; 30(5):513-20. PubMed ID: 10333219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spitz nevus and Reed nevus: simulating melanoma in adults].
    Paredes B; Hardmeier T
    Pathologe; 1998 Nov; 19(6):403-11. PubMed ID: 9885003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions.
    Li LX; Crotty KA; McCarthy SW; Palmer AA; Kril JJ
    Am J Dermatopathol; 2000 Dec; 22(6):489-95. PubMed ID: 11190439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children.
    Tom WL; Hsu JW; Eichenfield LF; Friedlander SF
    J Am Acad Dermatol; 2011 Mar; 64(3):559-72. PubMed ID: 21255872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.